Pluri (PLUR) Revenue & Revenue Breakdown
Pluri Revenue Highlights
Latest Revenue (Y)
$326.00K
Latest Revenue (Q)
$96.00K
Pluri Revenue by Period
Pluri Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-06-30 | $326.00K | 13.59% |
2023-06-30 | $287.00K | 22.65% |
2022-06-30 | $234.00K | 100.00% |
2021-06-30 | - | -100.00% |
2020-06-30 | $23.00K | -57.41% |
2019-06-30 | $54.00K | 8.00% |
2018-06-30 | $50.00K | 100.00% |
2017-06-30 | - | -100.00% |
2016-06-30 | $2.85M | 651.19% |
2015-06-30 | $379.00K | - |
2014-06-30 | $379.00K | -44.18% |
2013-06-30 | $679.00K | -5.17% |
2012-06-30 | $716.00K | -142.57% |
2011-06-30 | $-1.68M | 100.00% |
2010-06-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2008-06-30 | - | 100.00% |
2007-06-30 | - | 100.00% |
2006-06-30 | - | 100.00% |
2005-06-30 | - | 100.00% |
2004-06-30 | - | 100.00% |
2003-06-30 | - | 100.00% |
2002-06-30 | - | - |
Pluri Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $96.00K | 35.21% |
2024-03-31 | $71.00K | -32.38% |
2023-12-31 | $105.00K | 94.44% |
2023-09-30 | $54.00K | -51.35% |
2023-06-30 | $111.00K | 27.59% |
2023-03-31 | $87.00K | 4250.00% |
2022-12-31 | $2.00K | -97.70% |
2022-09-30 | $87.00K | 100.00% |
2022-06-30 | - | -100.00% |
2022-03-31 | $234.00K | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | -100.00% |
2020-06-30 | $29.19M | 100.00% |
2020-03-31 | - | -100.00% |
2019-12-31 | $23.00K | 100.00% |
2019-09-30 | - | -100.00% |
2019-06-30 | $20.60M | 100.00% |
2019-03-31 | - | -100.00% |
2018-12-31 | $50.00K | 1150.00% |
2018-09-30 | $4.00K | -100.78% |
2018-06-30 | $-515.00K | 100.00% |
2018-03-31 | - | -100.00% |
2017-12-31 | $50.00K | -90.29% |
2017-09-30 | $515.00K | -98.27% |
2017-06-30 | $29.74M | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | -100.00% |
2015-12-31 | $2.75M | 2796.84% |
2015-09-30 | $95.00K | 1.06% |
2015-06-30 | $94.00K | -1.05% |
2015-03-31 | $95.00K | - |
2014-12-31 | $95.00K | - |
2014-09-30 | $95.00K | 1.06% |
2014-06-30 | $94.00K | -1.05% |
2014-03-31 | $95.00K | - |
2013-12-31 | $95.00K | - |
2013-09-30 | $95.00K | - |
2013-06-30 | $95.00K | -51.03% |
2013-03-31 | $194.00K | -0.51% |
2012-12-31 | $195.00K | - |
2012-09-30 | $195.00K | 93.07% |
2012-06-30 | $101.00K | -56.09% |
2012-03-31 | $230.00K | -0.43% |
2011-12-31 | $231.00K | 50.00% |
2011-09-30 | $154.00K | 100.00% |
2011-06-30 | - | 100.00% |
2011-03-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2008-09-30 | - | 100.00% |
2008-06-30 | - | 100.00% |
2008-03-31 | - | 100.00% |
2007-12-31 | - | - |
Pluri Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
STRO | Sutro Biopharma | $153.73M | $25.71M |
RCUS | Arcus Biosciences | $117.00M | $48.00M |
FATE | Fate Therapeutics | $63.53M | $6.77M |
FHTX | Foghorn Therapeutics | $34.16M | $7.81M |
CGEN | Compugen | $33.46M | $2.56M |
MDWD | MediWound | $18.69M | $4.96M |
EVGN | Evogene | $5.64M | $4.19M |
BLRX | BioLineRx | $4.80M | $6.86M |
DYAI | Dyadic | $2.90M | $1.96M |
LUMO | Lumos Pharma | $2.05M | $488.00K |
PLUR | Pluri | $326.00K | $96.00K |
ENLV | Enlivex Therapeutics | - | - |
PPBT | Purple Biotech | - | - |
CSBR | Champions Oncology | - | $-14.06M |